Physician profile
Robert A Colman
NPI 1255497863
$2,760.29
in general payments reported to CMS, 2019-2025
20 companies · $570 in 2025
The $570 reported for 2025 was less than what a typical Allergy provider received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $144 · 2021: $324 · 2022: $449 · 2023: $431 · 2024: $455 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Education: $6.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,448.64 |
| Education | $6.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,372.41 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Genzyme Corporation | $718.40 | 2020-2025 | |
| Glaxosmithkline, LLC. | $250.85 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.86 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.40 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.39 | 2025 | |
| Csl Behring | $32.73 | 2025 | Hizentra |
| Regeneron Healthcare Solutions, INC. | $29.62 | 2022-2023 | Dupixent |
| Galderma Laboratories, L.P. | $28.64 | 2025 | Nemluvio |
| Kaleo, INC. | $27.63 | 2019 | |
| Biocryst US Sales Co., LLC | $17.46 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.33 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $17.11 | 2025 | Neffy |
| Incyte Corporation | $15.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.22 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.56 | 2022 | |
| Optinose US, INC. | $13.64 | 2019 | |
| Shire North American Group INC | $13.48 | 2019 | |
| Pfizer INC. | $13.24 | 2022 | |
| Alk-Abello, INC | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Colman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.